Valuation — not yet established
No valuation for Astarte Medical is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($12.6M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·Watchlist + deal alerts for Astarte Medical
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2021 | Later Stage VC (Series A1) | $7.6M | ▮ | ▮ |
| Apr 2019 | Early Stage VC (Series A) | $5.0M | ▮ | ▮ |
How Astarte Medical's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Astarte Medical, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Astarte Medical raised?
- Astarte Medical has raised $12.6M in total funding across 2 recorded rounds.
- When did Astarte Medical last raise?
- Astarte Medical last raised in Sep 2021 (Later Stage VC (Series A1)), raising $7.6M.